Cancer heterogeneity: converting a limitation into a source of biologic information

by Albert Rübben, Arturo Araujo
Published 2017-09-01

A systems approach defining constraints of the genome architecture on lineage selection and evolvability during somatic cancer evolution

by Albert Rübben, Ole Nordhoff
Published 2012-11-01

Cutaneous Basal Cell Carcinoma with Lymph Node and Pulmonary Metastases

by Renate U. Wahl, Claudio Cacchi, Albert Rübben
Published 2018-01-01

Correlative Monitoring of Immune Activation and Tissue Damage in Malignant Melanoma—An Algorithm for Identification of Tolerance Breakage During Immune Checkpoint Inhibitor Therapy...

by Renate U. Wahl, Marike Leijs, Arturo Araujo, Albert Rübben
Published 2020-03-01

Mutation analysis of multiple pilomatricomas in a patient with myotonic dystrophy type 1 suggests a DM1-associated hypermutation phenotype.

by Albert Rübben, Renate Ursula Wahl, Thomas Eggermann, Edgar Dahl, Nadina Ortiz-Brüchle, Claudio Cacchi
Published 2020-01-01

Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients

by Lucie Heinzerling, Elisabeth Livingstone, Selma Ugurel, Ulrike Keim, Valerie Glutsch, Peter Mohr, Katharina Kaehler, Sebastian Haferkamp, David Rafei-Shamsabadi, Claudia Pfoehler, Michael Weichenthal, Judith Sirokay, Nora Schlecht, Albert Rübben, Kerstin Schatton, Cindy Franklin, Lena Bischof, Andreas Meiwes
Published 2020-07-01